Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ambinter is a leading supplier of chemical compounds and screening libraries for the global drug discovery and life sciences community. Operating as a division of Greenpharma, the company offers an extensive portfolio of over 13 million screening compounds, building blocks, and specialized fragments. Their offerings include unique natural product-like collections and diverse chemical sets designed for high-throughput screening and lead optimization. Ambinter supports pharmaceutical companies, biotechnology firms, and academic researchers with high-quality chemical matter and custom synthesis services. The company is headquartered in Orléans, France, and maintains a strong presence in the medicinal chemistry service sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ambinter.